MagPortal.com   Clustify - document clustering
 Home  |  Newsletter  |  My Articles  |  My Account  |  Help 

Location: Categories / Finance & Investment / Stocks

Magazine articles on individual stocks, valuation, accounting standards, IPO's, brokerages, exchanges.
Old Articles: <Older 24701-24710 Newer>
The Motley Fool
July 23, 2007
Brian Lawler
Gilead's Great Growth The drugmaker announces another great quarter of growth. Investors, take note. mark for My Articles 140 similar articles
The Motley Fool
July 23, 2007
Rich Smith
Foolish Forecast: Northrop Knocking at the Door The defense contractor is set to report its second-quarter earnings. Investors, here is what you can expect to see. mark for My Articles 505 similar articles
The Motley Fool
July 23, 2007
Brian Lawler
Acquisitive Ways Paying Off for Genzyme A recently acquired drug yields positive study results. Genzyme investors, take note. mark for My Articles 186 similar articles
The Motley Fool
July 23, 2007
Anders Bylund
Rising Tide Lifts SanDisk And competition. Memory maker and gadget designer SanDisk just reported a better-than-expected quarter, with a little help from its friends -- and enemies. mark for My Articles 197 similar articles
The Motley Fool
July 23, 2007
Sham Gad
Earnings Are Not the Answer A lot of compelling outcomes are possible for FreightCar, any of which could generate some cold, hard cash for investors who are willing to be patient. mark for My Articles 6 similar articles
The Motley Fool
July 21, 2007
Rick Aristotle Munarriz
A Fool Looks Back International House of Pancakes is taking on a challenge with its purchase of the struggling Applebee's restaurant chain. It may gain a lunch and dinner market, but will it lose its 17 quarter earnings winning streak? mark for My Articles 84 similar articles
The Motley Fool
July 21, 2007
Rick Aristotle Munarriz
The Fool's Look Ahead Expect earnings reports this week from: Netflix... Amazon... Apple... Build-A-Bear Workshop... Chevron... etc. mark for My Articles 824 similar articles
BusinessWeek
July 30, 2007
Arlene Weintraub
Is Merck's Medicine Working? Spurred by the Vioxx fiasco, CEO Clark is trying to revamp the drug giant's culture. Analysts expect Merck's top line to grow 4%, to $23.5 billion this year, an achievement considering that sales growth had flatlined even before Vioxx imploded. mark for My Articles 595 similar articles
BusinessWeek
July 30, 2007
Gene G. Marcial
A Breakup At Brink's? Activist shareholders have upped pressure to spin off to shareholders the home security unit, so it can trade independently of the armored cars. mark for My Articles 10 similar articles
BusinessWeek
July 30, 2007
Roger O. Crockett
Zander May Be Running Out Of Minutes As profits vanish, will Motorola's board bump the CEO upstairs? Some investors say Zander has already run out of time and are calling for his removal. mark for My Articles 224 similar articles
<Older 24701-24710 Newer>    Return to current articles.